Monitoring and improving hypertension management in Xinjiang
Official title: Prognostic Model of Hypertension
Run by Xinjiang Medical University · NCT06160921 · Data updated 2026-11-12
This study is trying to improve how people with high blood pressure are treated in Xinjiang by tracking their health and treatment over ten years to find better ways to manage their condition.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 50000 (estimated) |
| Sponsor | Xinjiang Medical University Academic / other |
| Locations | 1 site (Ürümqi, Xinjiang) |
| Status | Recruiting |
| Started | January 1, 2020 |
| Main results expected | January 1, 2030 |
| Study ends | January 1, 2030 |
| Registry record updated | March 28, 2024 |
| Trial ID | NCT06160921 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients diagnosed with primary hypertension who are admitted to the First Affiliated Hospital of Xinjiang Medical University.
✕Probably not a fit
Patients with secondary hypertension, liver and kidney dysfunction, mental disorders, or those unwilling to participate will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to establish a comprehensive registration and monitoring system for patients with hypertension in Xinjiang from 2020 to 2030. It will collect real-world data on patient characteristics, treatment patterns, hospitalization outcomes, and complications associated with hypertension. The study seeks to develop effective treatment strategies and prevention guidelines to optimize patient management and reduce morbidity and mortality related to hypertension. By creating a platform for clinical research and translational medicine, the study aims to enhance the quality of care for hypertension patients in the region.
Why it matters
Potential benefit: If successful, this study could lead to improved management and outcomes for patients with hypertension.
How similar studies have gone: While similar observational studies have been conducted, this specific approach in Xinjiang is novel and aims to address local healthcare needs.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * A patient diagnosed with primary hypertension who was admitted to the First Affiliated Hospital of Xinjiang Medical University Exclusion Criteria: * Patients with secondary hypertension, patients with liver and kidney dysfunction, * patients with mental disorders, and patients who are unwilling to participate in this trial
Where it's running
-
The First Affiliated Hospital of Xinjiang Medicial University
Ürümqi, Xinjiang, China Recruiting
Study contacts
- Study coordinator: Xiang Xie, Phd
- Email: xiangxie999@sina.com
- Phone: 15099169036
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
IMB-guided health education to boost medication taking and blood pressure control in adults with hypertension
This study tests a health-literacy program based on Information-Motivation-Behavioral Skills to help adults with hypertension who don’t take their medicines regularly to take them more consistently and better control their blood pressure.
-
Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF
This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.
-
Hypertension: Does Education Help Patients Manage Blood Pressure Better?
This study tests whether structured patient education improves blood pressure control and self-management in adults with hypertension who speak Turkish.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
Long-term GW906 treatment for people with essential hypertension
This trial tests whether long-term GW906 injections are safe and effective for adults with essential hypertension who completed an earlier GW906 study.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.